J Neurogastroenterol Motil.  2022 Jan;28(1):111-120. 10.5056/jnm20250.

Development and Validity Assessment of a Self-evaluation Questionnaire for Functional Dyspepsia: A Multicenter Prospective Study in Korea

Affiliations
  • 1Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea
  • 2College of Medicine, Ewha Womans University, Seoul, Korea
  • 3Daegu Catholic University School of Medicine, Daegu, Korea
  • 4Dankook University College of Medicine, Cheonan, Chungcheongnam-do, Korea
  • 5Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Gangwon-do, Korea
  • 6Keimyung University School of Medicine, Daegu, Korea
  • 7Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea
  • 8College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 9CHA University, Ilsan Medical Center, Ilsan, Gyeonggi-do, Korea
  • 10Hanyang University College of Medicine, Seoul, Korea

Abstract

Background/Aims
Patient-reported outcomes (PROs) are essential for clinical decision making, conduction of clinical research, and drug application acquisition in functional gastrointestinal disorders. The aim of this study is to develop a PRO instrument and to determine the respondents’ perception of the efficacy of therapeutic agents for functional dyspepsia (FD).
Methods
A self-evaluation questionnaire for dyspepsia (SEQ-DYSPEPSIA) was developed and validated through a structured process. The 2-week reproducibility was evaluated, and the construct validity was assessed by correlating the scores of SEQ-DYSPEPSIA (including typical and major FD symptom subscales). Finally, the response to medication was assessed by comparing the changes after 4 weeks of treatment.
Results
A total of 193 Korean patients (age 48.5 ± 13.6 years, 69.4% women) completed the questionnaire. SEQ-DYSPEPSIA with 11 items had a good internal consistency (alpha = 0.770-0.905) and an acceptable test-retest reliability (intraclass correlation coefficient = 0.733-0.859). The self-evaluation questionnaire (SEQ)-major FD score highly correlated with the postprandial fullness/early satiety domain of the Patient Assessment of Gastrointestinal Symptom Severity Index (correlation coefficient r = 0.741, P < 0.001), Nepean Dyspepsia Index-Korean version (NDI-K) (r = 0.839, P < 0.001), and NDI-K quality of life (r = −0.275 to −0.344, P < 0.001). After medical treatment, decrease in the SEQ-typical FD and SEQ-major FD was significantly greater in the responder group than in nonresponder group (P= 0.019 and P = 0.009, respectively).
Conclusion
This study suggests that the Korean version of SEQ-DYSPEPSIA has good reliability and validity, and can be a useful PRO measurement tool in patients with FD.

Keyword

Dyspepsia; Patient outcome assessment; Surveys and questionnaires; Validation study
Full Text Links
  • JNM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr